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Abstract.  Human proinsulin and insulin oligomerize 
to form dimers and hemmers. It has been suggested 
that the ability of prohormones to self associate and 
form aggregates may be responsible for the sorting 
process at the trans-Golgi.  To examine whether insulin 
oligomerization is required for proper sorting into reg- 
ulated storage granules, we have constructed point 
mutations in human insulin B chain that have been 
previously shown to prevent formation of insulin hexa- 
mers (Brange, J.,  U.  Ribel, J.  E  Hansen, G.  Dodson, 
M.  T.  Hansen, S.  Havelund, S.  G. Melberg, E  Norris, 
K. Norris, L. Snel, A. R. Sorensen, and H. O. Voight. 
1988.  Nature [Lond.].  333:679-682).  One mutant 
(B10His--Asp) allows formation of dimers but not hexa- 
mers and the other (B9  s~r-'ap) prevents formation of 
both dimers and hexamers. The mutants were trans- 
fected into the mouse pituitary AtT-20 cells, and their 
ability to be sorted into regulated secretory granules 
was compared to wild-type insulin. We found that 
while B10His-~p is sorted somewhat less efficiently than 
wild-type insulin as reported previously (Carroll, R. J., 
R. E. Hammer, S. J.  Chan, H. H. Swift, A. H. Ruben- 
stein, and D.  E  Steiner.  1988.  Proc.  Natl.  Acad.  Sci. 
USA.  85:8943-8947;  Gross, D. J., P. A. Halban, C. R. 
Kahn, G. C. Weir, and L. Villa-Kumaroff. 1989.  Proc. 
Natl.  Acad.  Sci.  USA.  86:4107-4111).  B9Se~p is tar- 
geted to granules as efficiently as wild-type insulin. 
These results indicate that self association of proinsulin 
into hexamers is not required for its targeting to the 
regulated secretory pathway. 
T  FIE pathways of  protein secretion from neuroendocrine 
cells have been elucidated recently by DNA transfec- 
tion of cultured cells and experimental models using 
transgenic mice (reviewed in Kelly, 1985; Moore, 1987; also 
see Low et al., 1986).  Neuropeptides and hormones synthe- 
sized on membrane-bound ribosomes are first targeted to the 
rough ER,  where they enter the secretory pathway. While 
most secretory proteins are exported constitutively, peptide 
hormones are segregated away  from other proteins  at the 
trans-Golgi  (Orci et al., 1987) where they are packaged into 
dense-core storage granules. Secretion from these granules 
is not constitutive, but requires external cues in the form of 
neural or hormonal stimulation. 
The exact mechanisms for the sorting of peptide hormones 
at the trans-Golgi is not known. Studies using fusion proteins 
suggest that peptide hormones contain special sorting infor- 
mation and are actively sorted (Moore and Kelly, 1986). The 
identity of structural features encoding such information, 
however,  remains elusive. Recent studies of patients with a 
genetic  disorder,  familial hyperproinsulinemia, have pro- 
vided intriguing insights into the sorting problem. This dis- 
ease is characterized by increased serum levels of  proinsulin- 
like materials. In a  kindred with this disorder (Gruppuso 
et al.,  1984),  the hyperproinsulinemia was found to be as- 
sociated with a  point mutation in the B-chain coding re- 
gion of the insulin gene (Chan et al.,  1987).  Carroll et al. 
(1988) and Gross et al. (1989) have examined the cellular ba- 
sis for the defects of this mutant in transgenic mice and in 
transfected AtT-20  cells,  respectively.  In  both  cases,  the 
defects appear to result from a decrease in the efficiency of 
sorting  of the  mutant  proinsulin,  leading  to  heightened 
secretion of the unprocessed prohormone in an unregulated 
fashion. These observations suggest that the mutation may 
cause essential structural alterations such that the prohor- 
mone is not sorted efficiently.  The mutation results in the 
replacement of histidine with aspartic acid at position 10 of 
insulin B chain (Chan et al., 1987). Wild-type human insulin 
exhibits subunit interactions and forms dimers; dimeric insu- 
lin binds to Zn  2+ to form hexamers. The histidine residue at 
position B10 is involved in coordinating zinc ions (Blundell 
et al.,  1972),  and in the mutated form insulin dimers are 
formed instead of  hexamers (Brange et al., 1988). Therefore, 
an intriguing possibility is that the aggregation state of insu- 
lin is  important for its correct sorting into the regulated 
secretory pathway (Carroll et al., 1988; Gross et al., 1989). 
In this report, we set out to examine whether the intracel- 
lular transport and sorting of insulin is affected by its quater- 
nary structure. Brange et al. (1988) have recently character- 
ized  a  series  of mutant  insulins  with  altered  oligomeric 
states. These mutants, created by protein engineering, con- 
tain single amino acid substitutions and form insulin mono- 
mers or dimers instead of hexamers. We have chosen two of 
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B9  s~A~p contains  a  mutation  at  position  9  of insulin  B 
chain, and forms monomeric insulins even at high concen- 
trations  because  of  charge  repulsion  between  the  sub- 
unit-subunit interface. B10  His-A~p, as discussed earlier, forms 
dimeric insulins because of the lack of the Zn2+-coordinat  - 
ing histidine residue. Thus, although the molecular basis for 
their structural alterations is different, neither mutant can 
form hexamers. These mutations were introduced into hu- 
man proinsulin eDNA by site-specific mutagenesis, and their 
effects on  intracellular  targeting  were  assessed  by  DNA 
transfection into AtT-20 cells. This cell line has been shown 
to sort and process wild-type human proinsulin correctly, 
and therefore is a good model system to study sorting of mu- 
tant proinsulin (Moore et al.,  1983). We found that the ef- 
ficiency at which proinsulin is sorted does not correlate with 
its oligomeric state. Thus, the aggregation state of  human in- 
sulin does not dictate its intracellular localization. 
Materials and Methods 
The M13 vector, M13 hlns pBRC2-1mp8, with human insulin cDNA in- 
serted in the EcoRI and BamHI sites was kindly provided by Dr. C. Craik 
(University of California, San Francisco,  CA).  [32P]ATP for end-labeling 
mutagenic primers was obtained from ICN Radiochemicals  (Irvine, CA). 
Deoxyadenosine-5'-ct-[35S]thiotriphosphate  for  sequencing and  [35S]cys- 
teine were obtained from Amersham Corp. (Arlington Heights, IL). Oligo- 
nucleotide primers for mutagenesis and sequencing were purchased from 
the Biomolecular Resource  Center (University of California, San Fran- 
cisco).  Klenow  fragment for primer extension and restriction enzymes 
were  obtained from Boehringer Mannheim Biochemicals (Indianapolis, 
IN).  DNA ligase and polynucleotide kinase was from New England Bio- 
labs (Beverly, MA) and Pharmacia Fine Chemicals (Piscataway, NJ), re- 
spectively.  Sequenase  was from US Biochemical (Cleveland,  OH).  {3418 
was obtained from Gibco Laboratories (Grand Island, NY).  Guinea pig 
anti-porcine insulin antiserum was  obtained from Linco Research,  Inc. 
(Eureka,  MO).  [t25I]porcine insulin for RIA was supplied  by the Meta- 
bolic Research Unit (University of California, San Francisco).  PCS was ob- 
tained from Sigma Chemical Co.  (St.  Louis, MO). Formalin-fixed  Staph 
A cells (Immunoprecipitin) was obtained from Bethesda Research Labora- 
tories (Gaithersburg,  MD). 
Mutagenesis of  Human Proinsulin cDNA and 
Construction of  Plasmids 
Mutations of human proinsulin eDNA were constructed essentially as de- 
scribed previously (Fowell et al., 1988). For the B9Asp mutation, the 27met 
oligunucleotide,  5'-TTCCACCAGG~TCGCCGCACAGGTG-Y,  corre- 
sponding to the coding region flanking position 9 of human insulin B chain 
was used as mutagenic primer. For the Bl0Asp mutation, the mutagenic 
primer was 5'-AGCTTCCACCAGGTCTGAGCCGCACAG-3',  flanking po- 
sition 10 of B chain. For primer extension with Klenow fragment, a second 
oligonucleotide  corresponding to 21 bp of the insulin A-chain region was 
used. Phage plaques were screened using the appropriate end-labeled mnta- 
genic primer.  Positive  mutations were confirmed by dideoxy  sequencing 
(Sanger et al., 1977). The entire eDNA containing the individual mutation 
was excised from the M13 vector as an NcoI-BamHI fragment, and sub- 
cloned into the mammalian expression vector, pRSV-TGpoly(+)  (Powell et 
al.,  1988), via the unique NcoI-BglII sites.  Identity of the final plasmids 
was verified by restriction mapping. 
Cell Culture and Transfection 
AtT-20 cells were grown in DME H21 supplemented with 10% FCS under 
a  humidified  15%  COz  atmosphere.  CHO  cells  were  maintained  in 
HamsF12  supplemented with 10% FCS under 5% CO2. DNA transfection 
was carried out according to methods described previously  (Moore et al., 
1983).  For generating stable transfectants,  cells were cotransfected with 
120 rag of pRSV-hInsB9Asp or RSV-hInsBl0Asp and 24 nag of the selectable 
marker pSV2-noo.  Cells were selected with 0.25 mg/ml (active drug) of 
G418, and positive clones were screened by insulin radioimmunoassay  and 
by immunoprecipitation. Two stable lines from each mutant, B9Asp/29 
and B9Asp/38,  and B10Asp/3 and B10Asp/ll,  were  characterized.  AtT- 
20hlns.wt/7,  a cell line harboring wild-type insulin eDNA,  was used to 
compare intracellular transport of the mutant insulins with wild-type insu- 
lin. CHO cells were transiently transfected with 30 mg of insulin DNAs, 
and labeled with 3SS-cysteine between 42 and 65 h posttransfection. 
Metabolic Labeling and Determination 
of Sorting Efficiency 
Intracellular transport and sorting was quantitated according to the method 
described previously  (Moore and Kelly, 1985). Three 10-cm dishes of sub- 
confluent stable transfectants were labeled for either 30 min or 16 h with 
0.5  mCi of 135S]cysteine in cysteine-free  DME supplemented with 2% 
FCS. One dish of cells were extracted immediately  after labeling to quanti- 
rate the amounts synthesized.  For short-term labeling, cells were chased for 
three 1-h periods; during the third chase period 8-Br-cAMP was added to 
one dish at a final concentration  of 5 mM to stimulate regulated release from 
storage granules.  Cells were extracted at the end of the 3-h chase. For long- 
term labeling, cells were chased in unlabeled medium for three consecutive 
3-h periods.  During the 6-9-h chase, one dish of cells was stimulated with 
5 mM 8-Br-cAMP. Medium samples were collected and the cells were ex- 
tracted with NDET buffer (1% Nonidet P-40, 0.4%  deoxycholate,  66 mM 
EDTA,  10 mM Tris, pH 7.4) containing 0.3 mg/ml each of iodoacetamide 
and phenylmethylsulfonyl  fluoride.  The medium and extract samples were 
subjected to double imrnunoprecipitation and analyzed on a 10-18% SDS- 
PAGE (Moore and Kelly, 1986). To ensure quantitative immunoprecipita- 
tion, the titer of antiserum was determined and used at excess. Typically, 
each medium sample or 1/2 of extract samples were precipitated with 3 #1 
of the guinea pig anti-insulin serum and the immune complexes  were ab- 
sorbed with 60 ml of Immunoprecipitin (fixed Staph A cells).  The bands 
were quantitated by densitometric analysis  of the autoradiogram. 
Immunocytochemistry 
Light microscopy. Subconfluent cell cultures were fixed with Bouin's fluid 
or with 4% paraformaldehyde.  Cells were permeabilized by dehydration 
and rehydration with ethanol before incubation with anti-insulin serum (a 
girl from Dr.  P. Wright,  University of Indianapolis,  Indianapolis,  IN) for 
2 h at room temperature.  Cultures were washed with PBS (0.01 M phosphate 
buffer, pH 7.4, 0.15 M NaC1), and exposed to FITC-conjugated  second layer 
antibody for 1 hr at room temperature.  Ceils were washed with PBS, coun- 
terstained with 0.03 % Evans blue, and examined with an Axiophot fluores- 
cence  microscope  (Zeiss;  Oberkocben,  Germany).  Antibody  dilutions 
were:  guinea pig anti-insulin, 1:400; and sheep anti-guinea pig,  1:400. 
EM.  Cells were fixed for 20-120 rain with 1% glutaraldehyde  buffered 
in 0.1 M phosphate buffer (pH 7.4). After fixation, the cells were dehydrated 
with ethanol and embedded in Lowicryl K4M at low temperature (Arrnbrus- 
ter et al.,  1982). Thin sections of cells were collected  on nickel grids and 
immunolabeled by the protein A-gold method (Roth et al.,  1978).  Grids 
were incubated on a drop of the anti-insulin serum (dilution 1:1000) for 2 h, 
washed extensively with PBS, and then incubated for 1 h on a drop of pro- 
tein A-gold solution (size of gold particles =  15 nm). Washing was again 
carded out and the sections were counterstained with uranyl acetate and 
lead citrate before  examination in a Philips LS 400 electron microscope 
(Philips Electronic Instruments, Inc., Eindhoven, The Netherlands). 
Quantitative  Evaluation.  Immunngold particles were  quantitated on 
Golgi complex and dense-core secretory granules of the transfected cells. 
This was done on photographic prints (calibrated magnification  48,000x) 
with the aid of an electronic pen connected to a microprocessor (IBM PC; 
IBM Instruments, Inc., Danbury,  CT) programmed to record the number 
of gold particles per surface  area (#m  2) of the compartments drawn with 
the pen. 
Results 
Strategy 
To determine if  the oligomerization states of insulin influence 
its intracellular sorting and transport, we compared the path- 
ways  of secretion of insulins differing in their quaternary 
structures. Wild-type human insulin exists as a hexamer. We 
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5'...CAC CTG TGC GGC TCA CAC CrG GTG GAA Gcr...3' 
Wild type  His  Leu  Cys  Gly  Set  His  Leu  Val  Glu  Ala 
5  6  7  8  9  10  11  12  13  14 
B9ASP 
5'...CAC CIG TGC GGC GAC CAC CIG G'IG GAA Gcr...3' 
His  Leu Cys  Gly  /kXtz His  Leu  Val  Glu  Ala 
5  6  7  8  9  10  11  12  13  14 
BlOaSP 
5'...CAC CTG TGC GGC 1CA GAC CTG GTG GAA GCT...3" 
His  Leu  Cys  Gly  So"  A.~  Leu  Val  Glu  Ala 
5  6  7  8  9  10  11  12  13  14 
Figure L Structure of human insulin B-chain mutants used in this 
study. The amino acid sequences encompassing residues 5-14 of in- 
sulin  B  chain  and  the  corresponding  nucleotide  sequences  are 
shown.  Mutant  B9Asp contains  the codon GAC instead of TeA, 
resulting in the replacement of serine with aspartic acid at position 
9. In the mutant B10Asp the CAC codon at position  10 is changed 
to GAC; the resulting mutation has an aspartic acid in place of the 
histidine  residue. 
have constructed two variants in the coding region of insulin 
B chain: B9Asp, contains a serine to aspartic acid substitu- 
tion at position 9 of B chain, and B10Asp contains a histidine 
to aspartic acid substitution at position 10 of B chain. Brange 
et al. (1988) have studied the association states of these mu- 
tant insulins in highly purified preparations by osmometry, 
and showed that B9Asp is monomeric whereas B10Asp is di- 
meric. Thus, studying the behavior of these mutants in intra- 
cellular transport should shed important insights into the re- 
lationship between insulin hexamerization and sorting. 
Transfection  of CeU Lines with Human Proinsulin 
cDNAs Carrying Single Amino Acid Substitution in 
the B-chain Coding Region 
The mutations were introduced into human proinsulin cDNA 
by site-directed mutagenesis (Fig. 1). For each construct, the 
appropriate  27-met  mutagenic  primer  was  annealed  to  a 
copy of the human insulin cDNA that had been subcloned 
into M13mp8. Following primer extension and ligation, the 
DNA was transformed into Escherichia coli JM101 cells and 
transformants were screened for the mutation by plaque hy- 
bridization at increasing temperatures. Single-stranded DNA 
from several positive plaques was prepared and the mutation 
was confirmed by sequence analysis using the dideoxy meth- 
od (Fig. 2). DNA fragments carrying the desired mutations 
were subcloned into an RSV expression vector previously 
described for expression in tissue culture cells (Moore and 
Kelly,  1985). 
Expression of  Mutant Proinsulins in AtT-20 
and CHO Cells 
To study the intracellular transport of  mutated proinsulins, we 
transfected the plasmids into AtT-20 cells. Although derived 
Figure 2. Confirmation of insulin B9 and BI0 mutations by dideoxy sequencing. Site-specific mutagenesis was used to generate the desired 
mutations shown in Fig. 1. Single-stranded DNA obtained from positive M13 phage plaques was sequenced using a 21-mer oligonucleotide 
complementary to a region of the insulin A chain. Shown are sequences of the B-chain region targeted for mutation.  Note that the actual 
sequences determined  correspond  to the noncoding strand and read from bottom to top, 5'->3'. The triplet in open boxes corresponds 
to position 9 of the B chain, and the triplet in hatched boxes corresponds to position 10. The sequences showed the presence of the desired 
mutations. 
Quitm et al. Sorting of Mutant Insulin,  989 from corticotrophs in  the pituitary,  these cells have been 
shown previously to sort and process wild-type human pro- 
insulin correctly (Moore et al.,  1983). Stable cell lines har- 
boring mutated human proinsulins were generated by DNA 
transfection and selection with the antibiotic G418. Surviv- 
ing clones were expanded and screened for the production 
of immunoreactive insulins. Two positive clones, B9ASp/38 
and B10Asp/11, harboring plasmids containing the mutation 
at B9 and B10, respectively, were selected for study. The lev- 
els of  expression as determined by insulin radioimmunoassay 
were 167 ng per mg of acid extractable protein for B9Asp/38 
and 576 ng/mg for B10Asp/ll. A control cell line, Ins.wt/7, 
expressing wild-type human insulin at 221  ng/mg was used 
for comparison. The endogenous hormone ACTH was pro- 
duced at a much higher level (3-4/~g/mg). Thus, the amount 
of exogenous hormones produced is not likely to affect the 
sorting efficiency. 
Since many incorrectly folded protein8 are known to be re- 
tained within the cells, we first examined whether the mutant 
proinsulins can be secreted from the cells. Transfected AtT- 
20 cells were labeled with 35S-cysteine to steady state, and 
both media and cell extracts were immunoprecipitated with 
anti-insulin  antisera  (Fig.  3).  Cells  harboring  the  B9Asp 
plasmid  synthesized two molecular species that were im- 
munoreactive with anti-insulin. The larger one had the same 
apparent  mobility  as  proinsulin  on  SDS-PAGE,  and  the 
smaller one co-migrated with mature insulin.  Both species 
were secreted into the medium.  Cells transfected with the 
B10Asp plasmid showed a similar pattern (data not shown, 
and see below). Thus, despite the mutations affecting their 
oligomeric structures, a considerable portion of these proin- 
sulin variants are proteolytically processed into mature-size 
insulins in a way similar to wild-type proinsulin.  Further- 
more, unlike many misfolded proteins, they are not retained 
within the ER but can be secreted from the cells. Previously 
Figure 3.  Expression of the B9Asp insulin mutant in transfected 
cells. AtT-20  cells were transfected with an expression vector con- 
taining the B9Asp insulin. Stable clones were isolated and screened 
for production of the transfected gene product. Cells were radiola- 
beled with 35S-cysteine  for 16 h.  Labeling medium and cell ex- 
tracts were immunoprecipitated with an anti-insulin serum.  For 
comparison, CHO cells were transiently transfected with the same 
plasmid. The cells were radiolabeled at 42 h posttransfection for 
16 h, and the medium and extract samples were processed similarly. 
(Lanes 1 and 2) Samples from untransfected control CHO cells; 
(lanes 3 and 4) from transfected CHO cells; (lanes 5 and 6) from 
untransfected control AtT-20 cells; (lanes 7 and 8) from a stably 
transfected ART-20  cell line, B9Asp/29. Lanes 1, 3, 5, and 7are me- 
dia samples, and lanes 2, 4, 6, and 8 are cell extract samples. 
we have shown that proinsulin is processed to mature insulin 
in AtT20-cells, but not in other cells such as L cells (Moore 
et al.,  1983) or CHO cells (Quinn, D.,  and H. E  Moore, 
unpublished  results).  Proteolytic cleavage  of B9Asp  and 
B10Asp proinsulins  is also specific to AtT-20 cells:  CHO 
cells transiently transfected with the same plasmids synthe- 
sized and secreted only the larger species corresponding to 
the unprocessed precursor (Fig. 3). At the present, we do not 
know  if processing occurred at  exactly the same  sites  as 
wild-type insulin. 
Immunolocalization of the Proinsulin Variants 
As mentioned above, both B9Asp and B10Asp are secreted 
from the cells. Which pathway do they take? To determine 
if  the mutant proinsulins are targeted to the storage granules, 
we performed indirect immunofluorescence studies. In both 
B9Asp/38 and Bl0Asp/ll  cells, the structures stained most 
prominently with an anti-insulin serum are at the tips of cel- 
lular processes where dense-core granules congregate, and 
a  perinuclear region corresponding to the Golgi complex 
(Fig.  4).  By immunoelectron microscopy with the protein 
A-gold technique (Fig. 5), we confirmed a distinct labeling 
with the anti-insulin serum over both the Golgi complex and 
the dense-core secretory granule  compartments.  The im- 
munogold  labeling  intensity  in  B9Asp/38  and  B10Asp/ll 
clones was compared with that of AtT-20 cells transfected 
with wild-type insulin  and  with nontransfected cells.  The 
respective values of labeling are shown in Table I. Both mu- 
tants  are clearly present in the Golgi complex as well as 
dense-core granules.  Note that  the  actual  number of im- 
munogold particles detected simply reflected the level of ex- 
pression of the transfected DNA; the exact sorting efficien- 
cies cannot be determined accurately using this method (see 
below). Taken together, the data showed that both mutated 
proinsulins entered the regulated secretory pathway where 
they are proteolytically processed and localized to dense- 
core secretory granules. The B10Asp data are consistent with 
those of Carroll et al.  (1988) and Gross et al.  (1989) who 
showed that a  significant fraction of the B10Asp  was pro- 
cessed into mature insulin within the cells, presumably in 
dense-core secretory granules. 
Intracellular Sorting and Secretion of  Monomeric 
and Dimeric Proinsulins 
The above data showed that mutant proinsulins were targeted 
to the dense-core granules, but did not show how efficiently 
they were sorted into this organelle. To quantitate the target- 
ing efficiency, we analyzed intracellular sorting and secre- 
tion  of the  B9Asp  mutant  using  two  labeling-chase pro- 
tocols.  In  the  short-term  labeling  protocol,  cells  were 
metabolically labeled with 35S-cysteine for 30 min and then 
chased in unlabeled medium for two 1-h periods to collect 
proteins secreted by the constitutive pathway; the cells were 
then stimulated with 5  mM 8-Br-cAMP for 1 h  to induce 
secretion from the  regulated  secretory pathway.  Fig.  6  A 
shows a  direct comparison of the B9Asp mutant and wild 
type (pro)insulin using this protocol. As can be seen, both 
wild  type and  B9  mutant  proinsulin  were proteolytically 
processed within the cells to peptides of similar molecular 
size as  mature insulin.  Furthermore,  8-Br-cAMP induces 
secretion of both wild type and B9 mutant insulin; in both 
The Journal of Cell Biology,  Volume 113, 1991  990 Figure 4. Subconttuent cultures of AtT-20 cells transfected with mutant insulin cDNA (,4, B10Asp/11 clone; B, B9Asp/38 clone) were ana- 
lyzed by immunofluorescence using an anti-insulin serum. In both clones, the immunofluorescent staining is in the perinuclear (Golgi) 
region and cell periphery, most intense at the tip of cell processes (insets).  Bars, 20 #m. 
Quinn ctal. Sorting of Mutant Insulins  991 Figure 5. Fields of AtT-20 cells of the B10Asp/ll clone immunostained with anti-insulin revealed by the protein A-gold technique. (A) Abun- 
dant dense-core secretory granules (sg) in the peripheral cytoplasm (the tip of a cell process is shown in the upper part of the picture) 
are distinctly labeled by immunogold particles. (B) Golgi region (G) comprising cisternal-vesicular elements associated with a relatively 
low level of insulin immunoreactivity. A more heavily labeled dense-core secretory granule (sg) still connected to a cisternal element is 
visible in the lower right corner. The quantitative evaluation of the immunogold labeling over Golgi and secretory granule compartments 
in B10Asp and B9Asp clones is shown in Table I. Bars, 0.5  #m. 
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in AtT-20 Cells Transfected with Mutant Human Insulins 
Number of immunogold  particles/#m  2 of cell compartment 
B9Asp  BIOAsp  Wild type  Nontransfected 
Golgi complex (15)  6 +  1  8 +  1  10 +  2  0.7 +  0.2 
Secrett)ry granules (300)  108 5:5  308 5:17  277 5:13  2 5:1 
The number  of organelles  evaluated in each clone is indicated  in parenthesis. Shown is the mean  value followed by the standard error of the mean. An example 
of immunolabeling  (Bl0Asp) is shown in Fig. 5. 
cases, the secretagogue stimulated secretion three- to four- 
fold.  Thus,  sorting and processing is indistinguishable for 
the mutant and wild type proinsulin at this level of resolu- 
tion. To further confirm this result, we adopted a long-term 
labeling protocol that we have devised previously to quanti- 
tate  sorting  efliciencies  (Moore  and  Kelly,  1985).  This 
method is preferable over the short-term labeling protocol in 
that the amount of proteins entering the regulated pathway 
can be more accurately quantified.  This  is  necessary  for 
analyzing protein sorting in transfected cells in which the 
level of expression is relatively low, and in which the cell 
lines under study (such at AtT-20 cells) exhibit poor sorting 
Figure 6. Intracellular  transport and sorting 
of B9Asp mutant and wild-type insulin in 
transfected AtT-20 cells. (A) Short-term la- 
beling protocol.  (B)  Long-term  labeling 
protocol. For both protocols,  we used three 
identical dishes of B9Asp/38  and Ins.wt/7 
cells harboring the B9 mutant and wild-type 
insulin, respectively.  For short-term label, 
cells were  pulse labeled for  30 rain with 
35S-cysteine, and one dish of cells was ex- 
tracted immediately  after labeling.  The other 
two dishes were chased  for three  1-h peri- 
ods.  During the third chase,  one dish was 
stimulated with 5 mM 8-Br-cAMP. Labeled 
materials remaining in cells were extracted 
after the chase. Insulin  immunoreactive  ma- 
terials were precipitated with an anti-insulin 
serum, and analyzed  on 10-18  % SDS-PAGE. 
For long-term  label, cells were radiolabeled 
with 35S-cysteine for  16 h.  Cells from one 
dish  were  extracted  to  determine the  to- 
tal amount synthesized,  and the other two 
dishes were chased with unradiolabeled  me- 
dium  for  three  consecutive  3-h  periods. 
During the 6-9 h chase period, one dish of 
cells were incubated  with 5 mM 8-Br-cAMP 
to stimulate secretion  from storage granules. 
The other dish of cells was left unstimulated 
as control.  Cells were extracted  at the end 
of the chase periods.  (.4) Lanes 1-7 are the 
B9 mutant, and lanes 8-14 are wild-type in- 
sulin. Lanes 1 and 8 are  secretion during 
0-1 h chase, and lanes 2 and 9 are secretion 
during 1-2 h chase; lanes 3 and lOare secre- 
tion during 2-3-h chase  from  stimulated 
cells,  and lanes 4 and 11 are from control 
cells during the same period. Lanes 5 and 
12 are cell extracts immediately after label- 
ing; lanes 6 and 13 are extracts  at the end 
of the  3-h chase from cells  that had been 
stimulated,  and lanes  7 and  14 are  from 
control unstimulated cells.  (B) Lanes 1-9 
are  the  B9  mutant,  and lanes  10-18 are 
wild-type insulin. Lanes 1, 2, 10, and 11 are medium samples collected during 0-3-h chase; lanes 3, 4, 12, and 13 are medium samples 
collected during 3-6-h chase; lanes 5 and 14 are medium samples from cells stimulated with 8-Br-cAMP during 6-9-h chase, and lanes 
6 and 15 are from control unstimulated cells during the same period. Lanes 7 and 16 are cell extracts  immediately after labeling; lanes 
8 and 17 are extracts  at the end of the 9-h chase from cells that had been stimulated,  and lanes 9 and 18 are from control cells. 
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to steady state for  16 h  with 3sS-cysteine.  The ceils were 
then chased in unlabeled medium for two 3-h periods to al- 
low constitutive secretion to occur. The cells were then in- 
cubated for 3 h in the presence of 8-Br-cAMP, which stimu- 
lates the secretion of hormone stored in regulated secretory 
granules. Fig. 6 B shows an example of the autoradiographic 
analysis of secretion from wild type Ins.wt/7 cells and from 
the mutant B9Asp/38 cells using this protocol. This experi- 
ment was repeated several times using two different clones 
transfected with B9Asp,  and a summary of the quantitation 
of the results is shown in Table II. In both cases, ~12-14% 
of the  total  immunoreactive molecules after the  labeling 
period were mature-sized insulin.  If one assumes that the 
mature form is a measure of the amount stored in regulated 
secretory granules (Moore et al., 1983; also see below), this 
indicates that in both cells approximately the same fraction 
of immunoreactive insulin in the biosynthetic pathway is in 
storage granules. This point is further demonstrated by the 
fact that 8-Br-cAMP caused a similar level of stimulation of 
wild-type and mutant insulins during 6-9-h chase (13.6 and 
10%, respectively). The amount of intracellular storage at 
the end of  chase is also similar for both wild-type and mutant 
insulins (54 % for wild type and 58 % for B9Asp). We noticed 
that a significant fraction of the transfected products are still 
in the form of unprocessed proinsulin even after 9 h of chase; 
this is true both for wild type and B9Asp mutant insulin. It 
is possible that a fraction of human proinsulin is not folded 
properly in AtT20-cells and are retained within the ER. De- 
spite this, the data show that B9Asp mutant protein is han- 
dled very similarly to the wild type protein in AtT-20 cells. 
The major difference that we detected is that during a 9-h 
chase period, 25 %  of labeled mutant proinsulin were re- 
leased in a constitutive fashion compared to only 12%  of 
wild-type proinsulin.  This difference is mostly because of 
differences in the amounts recovered: at the end of the 9-h 
chase, we could not recover 31% of wild type immunoreac- 
tive (pro)insulin from either the cell extracts or the media; 
this amount is less (16%) for mutant (pro)insulin. At present, 
we cannot distinguish whether they were degraded intracel- 
lularly or lost from the media. A similar result was also ob- 
tained using the short labeling protocol (see Fig. 6 A). Thus, 
the B9 mutant is transported and processed by the cells in 
a  fashion very similar to wild-type insulin.  The only sig- 
nificant difference is that the mutant proinsulin appears to be 
more stable and/or more quantitatively recovered in the con- 
stitutively secreted media. 
We have also compared the sorting efficiency of B10Asp 
mutant with that of wild-type insulin and B9Asp  mutant. 
Using  a  protocol that  we describe previously to measure 
sorting index (Moore and Kelly, 1985), we quantitated the 
amount of proteins secreted by the regulated pathway relative 
to the amount released constitutively. Determination from 
two independent clones of  B10Asp mutant showed sorting in- 
dices of  0.40 +  0.005. Wild-type human insulin shows a sort- 
ing index of 0.66 (Powell et al.,  1988). Thus, the dimeric in- 
sulin B10Asp shows a slightly reduced efficiency of sorting, 
consistent  with  earlier  published  results  (Carroll  et  al., 
1988; Gross et al.,  1989). Monomeric insulin B9Asp shows 
a  sorting index of 0.67  +  0.02  and therefore is  sorted as 
efficiently as wild-type insulin. We concluded that hexamer- 
ization of insulin is not necessary for its correct sorting into 
the regulated secretory pathway. 
Discussion 
Recent studies on intracellular membrane traffic revealed a 
close relationship between the oligomerization state of a pro- 
Table II. Quantitation of  lntracellular  Transport of  Insulin Monomers and Hexamers in Transfected AtT-20 Cells 
Protein  Chase 1  Chase 2  Chase 3 (-sti)  Chase 3 (+sti)  Extract (-sti)  Not recovered 
Wild-type insulin hexamer 
No chase 
Pro  0  0  0  0  3,183  (88%) 
Mature  0  0  0  0  450 (12%) 
Total  0  0  0  0  3,633  (100%) 
Chase 
Pro  363  +  9  (10%)  76  +  4  (2%)  10 (0.2%)  <10  1,377 (38%) 
Mature  52  +  3  (1%)  31  ±  1 (1%)  16 (0.4%)  520 (14%)  567 (16%) 
Total  415  +  12 (11%)  107  ±  5  (3%)  26 (1%)  520 (14%)  1,944  (54%) 
B9Asp insulin monomer 
No chase 
Pro  0  0  0  0  3,501  (86%) 
Mature  0  0  0  0  564 (14%) 
Total  0  0  0  0  4,065  (100%) 
Chase 
Pro  742  +  68 (18%)  190  -t- 5  (5%)  70 (2%)  <20  1,806 (44%) 
Mature  27  +  25 (1%)  21  +  18 (1%)  <20  420 (10%)  552 (14%) 
Total  769  +  93 (19%)  211  ±  23  (6%)  70 (2%)  420 (10%)  2,358 (58%) 
1,141  (31%) 
657 (16%) 
Three identical  dishes of Ins.wt/7 or B9Asp/38 or B9Asp/29 cells were labeled  with 3SS-cysteine for 16 h. Ceils from one dish were extracted for normalization. 
The remaining two dishes were chased for three 3-h periods. During the last (6-9 h) chase, one dish of cells was stimulated with 5 mM 8-Br-cAMP. Media 
samples from each of the chases were collected,  and the cells were extracted at the end of the 9-h chase. Media and extract samples were subjected to im- 
munoprecipitation and SDS-PAGE as in Fig. 6 B, and the autoradiograms were quantitated by scanning and integrating the peak areas. The numbers under no 
chase represent immunoreactive (pro)insulin in cells extracted immediately after labeling; the sum of proinsulin and insulin at this time point was taken as 100% 
and used for normalization of subsequent numbers. Chase 1', Chase 2', and Chase 3' represent media samples collected during 0-3, 3-6, and 6-9-h chases, respec- 
tively. The final cell extract numbers are those recovered at the end of 9-h chase from cells that had not been stimulated. Since proinsulin and mature insulin 
have the same number of cysteine, the peak areas were used without further correction as a measure of the relative  molar quantities of pro/insulin. 
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and Helenius,  1989).  The clearest examples are found in 
protein export from the ER, where assembled oligomers are 
rapidly transported out of the ER but unassembled subunits 
and misfolded proteins are retained.  In this case,  protein 
folding and quaternary structures are important for sorting 
between transport and retention. Whether oligomerization 
states also determine protein sorting at other steps of trans- 
port remains to be determined. In vitro studies showed that 
proinsulins from many species interact with zinc ions to 
form hexamers, and it has been postulated that the hexameric 
organization may play a role in the biosynthesis and intracel- 
lular transport of  insulin (Emdin et al., 1980). An interesting 
exception is that proinsulin in guinea pig islets does not self 
associate but is processed and secreted (Wood et al., 1975); 
it was unclear whether this reflected a difference in the tar- 
geting mechanism in guinea pig compared to other mam- 
malian cells. The studies reported in this ~aaper, however, in- 
dicate  that  the  intracellular  sorting  of human proinsulin 
between the constitutive and the regulated pathway is also not 
affected by its oligomerization state. 
Previous results showed that B10Asp is partially diverted 
from the regulated secretory pathway to an unregulated path- 
way. Our analysis of this mutant also showed a modest de- 
crease in the efficiency of sorting: B10Asp is sorted at ap- 
proximately two-thirds the efficiency of wild-type insulin 
(sorting index of 0.40 compared to 0.66). This level of diver- 
sion is comparable to that found in transgenic mice and in 
AtT-20 cells: Carroll et al. (1988) showed that only 85%  of 
the mutant prohormones were sorted into storage granules 
in the pancreas of transgenic mice compared to 97 % for the 
wild-type protein; Gross et al. (1989) showed that in AtT-20 
cells, 90% of labeled wild-type insulin was retained within 
the cells after a 30-min chase period whereas only 70% of 
B10Asp was retained. In all the studies, it is clear that a 
significant portion of the mutant insulin is still targeted to 
the storage granules and released by the regulated pathway. 
If the lowered sorting efficiency of B10Asp is because of 
dimer rather than hexamer formation, then B9Asp  should 
show equal or more severe reduction in sorting efficiency 
since only monomeric insulin is formed. This is clearly not 
the case. The sorting efficiency of B9Asp is indistinguishable 
from that of wild-type insulin. Thus, the lower sorting effi- 
ciency of B10Asp is most likely a result of other changes in 
the protein rather than its inability to form the proper oligo- 
meric structure. One possibility, as suggested by Carroll et 
al. (1988), is that the elevated affinity for insulin receptor of 
B10Asp may cause it to bind to the insulin receptor en route 
to the cell surface, thereby partially diverted to the constitu- 
tive route. The exact mechanism for the diversion of this mu- 
tant remains to be determined. 
The prediction that B9Asp and B10Asp form monomeric 
and dimeric proinsulin,  respectively, is based on in vitro 
studies using purified mutant insulins (Brange et al., 1988). 
Although it would be desirable to confirm the oligomeric 
states of the mutants in our transfected AtT-20 cells, this 
is technically unfeasible. Hexamer formation is reversible, 
and can be detected only at relatively high monomer concen- 
trations  (0.1-1 mg/ml) under equilibrium conditions. The 
amounts of  proteins expressed in the transfected cell lines are 
too low (0.1-1 mg/106 cells) to permit purification and anal- 
ysis  by  equilibrium  centrifugation or  osmometry.  Other 
methods for analyzing quaternary structure, such as velocity 
sedimentation of crude cell lysate, are only appropriate for 
detecting stable polymers which do not dissociate during the 
sedimentation procedure. We feel that the results obtained 
by Brange et al. (1988) should accurately predict the states 
of proinsulins in our transfected cells for reasons which fol- 
low.  Our  constructs contained the  identical mutations to 
theirs.  Although expressed  in different systems (theirs in 
yeast cells and ours in AtT-20 cells), these mutant proinsu- 
lins behaved similarly and were processed to mature insulins 
in both systems. Thus, the mutant insulins produced in Aft- 
20 cells should have the same structures as those purified 
from yeast cells.  Purified B9Asp  and B10Asp insulins are 
present as monomer and dimer, respectively, even at concen- 
trations as high as 1 mM (Brange et al., 1988).  The level of 
transfected insulins is  ~10-fold less than the endogenous 
ACTH, which has been estimated to be in the mM range in 
storage granules (Gumbiner and Kelly, 1981). Therefore, the 
concentration of insulins expressed in these cells is not likely 
to exceed the concentration used to determine their struc- 
tures in vitro. Although the structural determinations were 
performed on mature mutant insulins, the same oligomeric 
structures most likely also apply to the corresponding proin- 
sulins. The insulin moiety of the proinsulin molecule has 
been shown to exist in essentially the same conformation as 
the mature insulin molecule, and both proinsulin and insulin 
show similar type of interactions with zinc to form hexa- 
mers. Thus, the oligomeric states of the mutant proinsulins 
should show similar behavior as the corresponding insulins 
(Frank and Veros,  1970). 
Electron microscopic studies have shown that many pro- 
hormones  become  highly concentrated at  regions  of the 
trans-Golgi where dense-core granules are  forming (Sal- 
peter and Farquhar,  1981; Orci,  1974,  1982;  Orci et al., 
1987). This has led to the hypothesis that sorting of  this class 
of molecules into storage granules may be achieved by their 
ability to self aggregate in the milieu of the trans-Golgi (Bur- 
gess and Kelly, 1987).  The physical properties of insulin to 
form hexamer and larger aggregates make this a very attrac- 
tive idea. In addition, analysis of secretion of  von Willebrand 
factor from human endothelial cells has shown that different 
oligomeric forms of  this protein are secreted via the constitu- 
tive and the regulated pathways: molecules secreted constitu- 
tively are dimeric, whereas those secreted by the regulated 
pathway consist of only very large multimers (Sporn et al., 
1986).  One possible explanation of such differences is that 
sorting is driven by aggregate formation and that only the ag- 
gregated form is sorted into the regulated pathway. However, 
this is not the only possibility. Another equally likely expla- 
nation is that aggregate formation is not causal but rather a 
result of sorting-the high concentration of the sorted pro- 
teins may facilitate aggregate formation within the storage 
granules.  Our  finding  that  the  monomeric  proinsulin  is 
sorted at the same efficiency as hexameric proinsulin argues 
against the idea that sorting is achieved by self aggregation 
of the transported proteins. It should be noted, however, that 
although our data do not support homophilic protein-protein 
interactions as a primary mechanism for sorting, they do not 
exclude the possibility that heterophilic aggregate formation 
may be important for sorting. In the transfected AtT-20 cell 
system, the exogenous proinsulin is sorted along with endog- 
enous ACTH and other storage granule proteins (Moore et 
Quinn et al. Sorting  of  Mutant Insulins  995 al., 1983). It is possible that proinsulin  binds to endogenous 
secretory proteins to form heteropolymers which are then 
segregated.  Heteropolymer  formation  has  recently  been 
documented for pancreatic secretory products (Tooze et al., 
1989),  and  hormones can be cross-linked by heterophilic 
protein-protein interactions  (Chung et al., 1989). Future ex- 
periments will be necessary to determine the exact role of 
such heteropolymer formation  in the sorting  of regulated 
secretory proteins. 
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